After announcing its €15 million Serie A funding round, the sustainable chemical company GFBiochemicals entered into an agreement with German chemical giant BASF. Specifically, BTC Europe GmbH, BASF’s European distribution organization, and NXTLEVVEL Biochem, a joint venture and manufactoring arm of GFBiochemicals, signed an agreement on the distribution of biobased and biodegradable solvents derived from levulinic acid for the European market.
A consortium, including LanzaTech and Danone, led to the discovery of a new route to monoethylene glycol, (MEG), which is a key building block for polyethylene terephthalate, (PET), resin, fibers and bottles. The technology converts carbon emissions from steel mills or gasified waste biomass directly into MEG. The carbon capture technology uses a proprietary engineered bacterium to convert carbon emissions directly into MEG through fermentation, bypassing the need for an ethanol intermediate, and simplifying the MEG supply chain. The direct production of MEG was proven at laboratory scale and the presence of MEG was confirmed by two external laboratories.
The US bioeconomy takes a step forward. Genomatica, Cargill, HELM and Qore completed a groundbreaking ceremony in Eddyville, Iowa, to celebrate the construction of the first, bio-1,4-butanediol (BDO) facility to be built in the U.S. and the second bio BDO commercial scale plant for Geno. It’s a major milestone for biotech to supply more sustainable materials to meet surging consumer demand, while advancing manufacturing right in America’s heartland.
The BMW Group has chosen to use BASF Coatings’ CathoGuard® 800 ReSource e-coat at its plants in Leipzig, Germany, and Rosslyn, South Africa, and the iGloss® matt ReSource clearcoat throughout Europe. Using these more sustainable product versions for vehicle coatings enables CO2 avoidance of around 40% per coating layer; this will reduce the amount of CO2 emitted in the plants by more than 15,000 metric tons by 2030.
BRAIN Biotech AG and Formo Bio GmbH launched a strategic collaboration to further advance the production of animal-free milk proteins. BRAIN Biotech is a leading industrial biotechnology company, Formo is a pioneering food-tech startup in the space of alternative milk protein. As experts in their field, the two German biotech companies are powering European innovation.
UPM Biochemicals and KRAHN Chemie Deutschland GmbH signed an exclusive distribution agreement to market UPM BioMotion Renewable Functional Fillers (RFF) in Germany, Austria and Switzerland. RFF are a completely new category of functional fillers, replacing fossil-based carbon black and precipitated silica. The distribution agreement covers UPM BioMotion X10, X20 and X40 product grades to be used in plastics, adhesives and sealants as well as paints and coatings.
Elanco Animal Health Incorporated and DSM have created a strategic alliance connecting two leading, sustainability-focused companies to address one of society’s most significant opportunities of the decade, mitigating climate change by reducing greenhouse gas emissions from farming. Elanco has secured the exclusive U.S. licensing rights to develop, manufacture and commercialize Bovaer® for beef and dairy cattle. Bovaer® is a first-in-class and best-in-class methane-reducing innovative feed additive for beef and dairy cattle, already available in Europe, Brazil, Chile and Australia. More than 50 peer-reviewed studies and 48 on-farm trials in 14 countries show Bovaer® consistently reduces enteric methane emissions by approximately 30% for dairy cows and even higher percentages for beef cattle.
Refuel Energy Inc. (Refuel) will construct a 3000 barrels per day renewable fuel plant in Southern Ontario, Canada. The proposed project, called Refuel YYZ, would supply the aviation and terrestrial fuel needs of the Greater Toronto area, home to 6 million Canadians, while lowering the CO2 emissions for the end users by up to 80%. It is also strategically located for exporting to the US Northeast.
Bridgestone Americas, a global leader in tires and sustainable mobility solutions, signed an exclusive partnership with Carbon Capture and Transformation (CCT) company LanzaTech NZ to address end-of-life tire waste. The two companies will co-develop the first dedicated end-of-life tire recycling process leveraging LanzaTech’s proprietary CCT technology, creating a pathway toward tire material circularity and the decarbonization of new tire production.
Canadian company Enerkem, a world leader in the production of low-carbon intensity biofuels and circular chemicals from waste materials, closed a new financing totaling $255 million. Repsol invests $170 million, of which $75 million is in Enerkem’s equity and $95 million in convertible debt. In doing so, Repsol joins existing shareholder Suncor Energy as a strategic shareholder to accelerate the adoption and deployment of Enerkem’s technology and to develop new projects in the Iberian Peninsula (Spain and Portugal). In addition, Monarch Alternative Capital, a new investor, is contributing $30 million to the round while Avenue Capital Group is reinvesting $30 million, both in convertible debt. Finally, there is $25 million reinvested in equity by some existing shareholders.
IL BIOECONOMISTA 